Lives Inspired Breast Cancer Survivor Book, Plus Leukemia Cell Research

In keeping with the theme of collecting inspirational stories of hope after a cancer diagnosis, I found a book you might want to add to your collection. Called “Lives Inspired: Portraits of Breast Cancer Survivors,” “it was just released last month and offers a beautiful portrayal in pictures and words of the struggles and victories of breast cancer survivors.

Written by Carolyn Hones, CEO of Privacy Wear, is pricey – at $44, but it is a coffee table size book sure to be looked upon as a piece of art. The portraits are brilliantly illustrated and their stories are filled with courage and determination, sure to warm your heart.
To order this book or more information, go to:
http://www.privacywear.com/shop/view/?id=422

Different compounds found to kill leukemia cells

A new class of chemical compounds has proven in lab tests with human cells and in mice to be highly effective in targeting and killing leukemia cells, while being tolerated well by normal blood cells, researchers say. They say their findings on substances that inhibit the enzyme mTor and do so in a different way than current drugs to could lead to clinical trials and new, improved treatment for leukemia.

To read the original study in the Nature, go here:
http://www.nature.com/nm/journal/vaop/ncurrent/full/nm.2091.html

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap